HIGHLIGHTS
- who: Soumia Maach from the Department of Neurosciences, Psychology, Drug Research and Child Health (NeuroFarBa), University of Florence, Florence, Italy have published the research work: Dual HDAC-BRD4 inhibitors endowed with antitumor and antihyperalgesic activity, in the Journal: (JOURNAL) of 22/09/2010
- what: The authors report the design synthesis and activity of new obtained by adding a methyltriazole moiety to some HDAC carrying a benzodiazepine core which were previously developed by us. While this work was in progress, compounds with structure similar to 6, deriving from hybridization of SAHA and JQ1, were reported in . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.